Picture of Asimilar logo

ASLR Asimilar News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsHighly SpeculativeMicro CapSucker Stock

REG - Asimilar Group PLC - Further conditional investment in Dev Clever




 



RNS Number : 0196H
Asimilar Group PLC
01 December 2020
 

Asimilar Group Plc

("Asimilar" or the "Company")

 

Further conditional investment in Dev Clever

 

 

Asimilar Group plc (AIM: ASLR), the AIM quoted investment company focused on technology opportunities in the fields of big data, machine learning, telematics and the Internet of Things (IoT), provides an update on its investment in Dev Clever Holdings plc ("Dev Clever").

 

Asimilar's wholly owned subsidiary, Intrinsic Capital (Jersey) Limited ("ICJL"), has conditionally subscribed for 20,000,000 new shares in Dev Clever at a subscription price of 10p per share ("the Subscription Shares"), being the second tranche of its subscription rights to invest in new shares in Dev Clever.

 

ICJL has agreed with Dev Clever to amend the terms of its investment agreement so that completion of the second subscription is conditional on either (1) Dev Clever publishing a prospectus approved by the FCA on or before 25 January 2021; or (2) the issue and admission of the Subscription Shares in respect of the second tranche being exempt from the requirement for publication by Dev Clever of a prospectus.

 

Asimilar currently has an interest in 20 million shares in Dev Clever (representing 4.2% of Dev Clever's issued share capital).  On completion of the second subscription, Asimilar would have an interest over 8.1% of Dev Clever's enlarged issued share capital.

 

Dev Clever is listed on the Standard List of the London Stock Exchange.  The subscription for the third and fourth investment tranches remains conditional on the publication of a prospectus by Dev Clever. 

 

Asimilar is in discussions with Dev Clever about the opportunity to accelerate the two remaining investment tranches, subject to the publication by Dev Clever of a prospectus.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. The Directors of the Company take responsibility for this announcement.

 

**ENDS**

Contacts

Asimilar Group plc


John Taylor, Non-Executive Chairman

via Buchanan



Cairn Financial Advisers LLP


Sandy Jamieson / Liam Murray

Tel: +44 20 7213 0880



Peterhouse Capital Limited


Duncan Vasey / Lucy Williams

Tel: + 44 20 7220 9797



Buchanan Communications Limited


Richard Oldworth / Chris Lane

Tel: +44 (0) 20 7466 5000

 

Caution regarding forward looking statements

 

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKKKBQDBDBBDN

Recent news on Asimilar

See all news